Carbinoxamine Maleate Extended-release Oral Suspension Suspension, Extended Release
Product Images NDC 62542-101

4 FDA label images from Neos Therapeutics, Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbinoxamine Maleate Extended-release Oral Suspension (NDC 62542-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Neos Therapeutics, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure 1 (Structure 1)

Structure 1 (Structure 1)
Chemical structure diagram of Carbinoxamine Maleate, showing its molecular configuration with labeled atoms and bonds.*
FDA Label Image

Structure 2 (Structure 2)

Structure 2 (Structure 2)
Chemical structure diagram of Carbinoxamine Maleate illustrating the molecular arrangement with labeled functional groups and atoms.*
FDA Label Image

Karbinal-label-16oz (Karbinal Label 16oz)

Karbinal-label-16oz (Karbinal Label 16oz)
Label for Carbinoxamine Maleate Extended-Release Oral Suspension, 4 mg/5 mL, strawberry banana flavored, in a 16 fl oz (480 mL) bottle. The label includes dosing instructions to shake well and dose every 12 hours with an accurate milliliter measuring device. Manufactured by Tris Pharma, Inc. for Neos Therapeutics.*
FDA Label Image

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.